CUSIP 04280A100COMARWRQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
397 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 21.32M | $1.42B | +1.09M | Added |
| 2 | Vanguard Group Inc | 15.29M | $1.02B | −742.7K | Reduced |
| 3 | Avoro Capital Advisors LLC | 10.63M | $705.39M | −275.0K | Reduced |
| 4 | Fmr LLC | 6.52M | $432.89M |
| Added |
| 5 | State Street Corp | 6.40M | $425.15M | +6.5K | Added |
| 6 | Geode Capital Management, LLC | 3.26M | $216.80M | +133.9K | Added |
| 7 | Slate Path Capital LP | 2.52M | $167.54M | −2.46M | Reduced |
| 8 | Baker Bros. Advisors LP | 2.18M | $144.44M | +504.9K | Added |
| 9 | Arrowstreet Capital, Limited Partnership | 2.09M | $138.62M | +6.3K | Added |
| 10 | Fred Alger Management, LLC | 1.83M | $121.69M | +1.53M | Added |
See every fund holding Arrowhead Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders